Author Archives for Adeline Chauvigné

InFlectis BioScience licenses rights to a potential new class of therapies for demyelinating diseases from the University of Chicago

19 September 2025

InFlectis BioScience has been granted exclusive patent rights from the University of Chicago to use a family of small molecules for the treatment... View Article

Jessica Walker has been elected Board Member of the Council of European Bioregions!

19 September 2025

Atlanpole Biotherapie’s European project manager Jessica Walker has been elected Board Member of the Council of European Bioregions! This European... View Article

Oncology: infrared light could help surgeons see more clearly the tumors during operations

19 September 2025

The University Medical Center Groningen and Kaer Labs announce entering into a research collaboration to evaluate NIR-II fluorescence for biological... View Article

New partner | 2 do it

19 September 2025

Engaged in relational performance in business, Lucie Léger strongly believes that we can transform businesses and employees ! Reinvent relational... View Article

New partner | SinnRJ

19 September 2025

SinnRJ’s core activity is to support innovative structures (SMEs, large groups, academic laboratories) in obtaining regional, French and especially European... View Article

New partner | Strategiqual

19 September 2025

Strategiqual is a leading consultancy organization highly skilled for drugs, medical devices and in vitro medical devicesprojects. Strategiqual provides companies... View Article

New partner | Alison Munro

19 September 2025

25+ years dedicated to Health innovation. Founded Alison Munro Corporate Language (AMCL) in 2005. Has coached 350+ startups & top-notch... View Article

Valneva completes recruitment for Phase 3 Lot-to-Lot Consistency Trial of its Chikungunya Vaccine Candidate

19 September 2025

Valneva,  a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet... View Article

Valneva completes Phase 3 trial recruitment for its inactivated COVID-19 vaccine candidate

19 September 2025

Valneva , a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant... View Article

New member | Learn & Go

19 September 2025

Kaligo digital learning book, initially dedicated to early childhood, is based on the stages of the active learning approach: production... View Article